top of page

From Strategy to Funding

D4 Bioventures helps life science and healthcare companies define commercial strategy, become investment ready, raise capital, and execute partnering or exit transactions.

Our Product Suite

peoplelogo_edited_edited_edited.png

Commercial Strategy Workshop

Define value proposition, business model, and strategic priorities with clear direction.

Learn More
investment_edited_edited_edited_edited.p

Investor Readiness
 

Convert strategy, evidence, development plan and go-to-market logic into compelling investor-ready materials.

Learn More
abstract (1)_edited_edited_edited.png

Managed Capital
Raise

Disciplined, structured capital raise process with consistent execution and momentum.

Learn More
abstract (4).png

Strategic Transactions
& Exit

Identify and engage strategic partners or acquirers, support term sheet negotiation, diligence and close.

Learn More

Why Teams Choose to Work with D4 Bioventures

Domain Expertise

Deep experience across biotech, medtech, diagnostics, and digital health, from technical assessment to commercial strategy.​

Investor Lens

We shape opportunities around the questions that investors, partners and acquirers will test.​​

​

​

Capital Access

We connect companies with relevant institutional, family office, HNWI and strategic investors across Australia and APAC, including Singapore and Hong Kong.

Deal Judgement

We understand how strategic value, risk, timing and negotiation shape successful transactions.

​

​

Outcome Focused

We focus on practical steps that add value by moving opportunities towards investment, partnering, licensing or exit.

​

Let’s Start the Conversation

Get in touch to discuss your opportunity and the right next step.

D4 Bioventures horizontal logo

SWG Capital Pty Ltd, (ABN 37 135 455 864) as a Corporate Authorised Representative (CAR No. 001296052) of FB Corp Pty Ltd, (ABN 16 675 876 490) (AFSL No. 557810)

The information in this website (the Information) has been prepared by SWG Capital. This information is for general information only and is not an offer for the purchase or sale of any financial product or services. The Information has been prepared for investors who qualify as wholesale clients under section 761G of the Corporations Act 2001 (Cth) (Corporations Act) or to any other person who is not required to be given a regulated disclosure document under the Corporations Act. The Information is not intended to provide you with financial or tax advice and does not take into account your objectives, financial situation or needs. Although we believe that the Information is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given the Licensee, SWG Capital or any other person. To the maximum extent possible, the Licensee, SWG Capital or any other person do not accept any liability for any statement in this Information.

© 2026 D4 Bioventures. All Rights Reserved.

Privacy Policy

bottom of page